{"version":3,"file":"V3SubstanceAdminSubstitutionReasonCodes.js","sources":["../../src/fhirValueSets/V3SubstanceAdminSubstitutionReasonCodes.ts"],"sourcesContent":["// <auto-generated/>\r\n// Contents of: hl7.fhir.r4.core version: 4.0.1\r\n// Minimum TypeScript Version: 3.7\r\n// FHIR ValueSet: http://terminology.hl7.org/ValueSet/v3-SubstanceAdminSubstitutionReason|2014-03-26\r\n\r\n/**\r\n * No Description Provided\r\n */\r\nexport const V3SubstanceAdminSubstitutionReasonCodes = {\r\n  /**\r\n   * CT: Indicates that the decision to substitute or to not substitute was driven by a desire to maintain consistency with a pre-existing therapy.  I.e. The performer provided the same item/service as had been previously provided rather than providing exactly what was ordered, or rather than substituting with a lower-cost equivalent.\r\n   */\r\n  ContinuingTherapy: \"CT\",\r\n  /**\r\n   * FP: Indicates that the decision to substitute or to not substitute was driven by a policy expressed within the formulary.\r\n   */\r\n  FormularyPolicy: \"FP\",\r\n  /**\r\n   * OS: In the case of 'substitution', indicates that the substitution occurred because the ordered item was not in stock.  In the case of 'no substitution', indicates that a cheaper equivalent was not substituted because it was not in stock.\r\n   */\r\n  OutOfStock: \"OS\",\r\n  /**\r\n   * RR: Indicates that the decision to substitute or to not substitute was driven by a jurisdictional regulatory requirement mandating or prohibiting substitution.\r\n   */\r\n  RegulatoryRequirement: \"RR\",\r\n} as const;\r\n\r\n/**\r\n * No Description Provided\r\n */\r\nexport type V3SubstanceAdminSubstitutionReasonCodeType = typeof V3SubstanceAdminSubstitutionReasonCodes[keyof typeof V3SubstanceAdminSubstitutionReasonCodes];\r\n"],"names":[],"mappings":";;AAAA;AACA;AACA;AACA;AAEA;;AAEG;AACU,IAAA,uCAAuC,GAAG;AACrD;;AAEG;AACH,IAAA,iBAAiB,EAAE,IAAI;AACvB;;AAEG;AACH,IAAA,eAAe,EAAE,IAAI;AACrB;;AAEG;AACH,IAAA,UAAU,EAAE,IAAI;AAChB;;AAEG;AACH,IAAA,qBAAqB,EAAE,IAAI;;;;;"}